Single drug or multiple drug therapy for epilepsy?

Anglo-French neurological interactions in the 19th and early 20th centuries: Societies and Journals.

Revue neurologique·2022

Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events.

Revue neurologique·2021

Allbutt of Leeds and Duchenne de Boulogne: Newly discovered insights on Duchenne by a British neuropsychiatrist.

Revue neurologique·2018

Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.

Journal of neurology·2017

A brief history of hysteria: From the ancient to the modern.

Handbook of clinical neurology·2016

What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies.

European journal of clinical nutrition·2016

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Psoriasis.

Lancet (London, England)·2026

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2026

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Lancet (London, England)·2026

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

Lancet (London, England)·2026

PAI-1 As a Therapeutic Target: A State-of-the-Art Review.

Seminars in thrombosis and hemostasis·2026

Beyond mood: the neurobiological rationale for using SSRIs and SNRIs in the care of inflammatory bowel disease and disorders of gut-brain interaction.

Minerva gastroenterology·2026

Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.

Health expectations : an international journal of public participation in health care and health policy·2026

Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

The Journal of rheumatology·2026

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

EULAR rheumatology open·2026

Onset of Motor Complications and Medication Dose in Newly Diagnosed and Treated Parkinson's Disease.

Parkinson's disease·2026

Related Experiment Videos

Single drug or multiple drug therapy for epilepsy?

Related Concept Videos

Anglo-French neurological interactions in the 19th and early 20th centuries: Societies and Journals.

Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events.

Allbutt of Leeds and Duchenne de Boulogne: Newly discovered insights on Duchenne by a British neuropsychiatrist.

Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.

A brief history of hysteria: From the ancient to the modern.

What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Psoriasis.

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial.

PAI-1 As a Therapeutic Target: A State-of-the-Art Review.

Beyond mood: the neurobiological rationale for using SSRIs and SNRIs in the care of inflammatory bowel disease and disorders of gut-brain interaction.

Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.

Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.

Onset of Motor Complications and Medication Dose in Newly Diagnosed and Treated Parkinson's Disease.

Related Experiment Videos

Single drug or multiple drug therapy for epilepsy?

Related Concept Videos

Related Articles